When to pause or discontinue a protocol The calculator tells you what to draw
BURN FAT AND BOOST METABOLISM
The primary objective was to determine whether FARXIGA reduces the incidence of the composite endpoint of 50% sustained decline in eGFR, progression to end-stage kidney disease (ESKD) (defined as sustained eGFR 40% and evidence of structural heart disease to determine whether FARXIGA reduces the risk of CV death, hospitalization for heart failure or urgent heart failure visits
The Zoox expansion marks another step as the Amazon-owned startup continues scaling operations across major metro areas.In a growing landscape of fully autonomous robotaxi networks in the US, Zoox remains one of the bigger names in its segment, competing against other heavy-hitters like Tesla, Waymo, and, more recently, Nuro.What sets the Amazon-backed robotaxi developer apart fr
As more studies explore the optimal benefits of GLP-1 medications in heart disease, cognitive disorders, kidney health, and addiction, the scope of these medications is expanding beyond their original usage
